(Q41838846)

13 October 2017

Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome (English)

1 reference

13 October 2017

Guillain–Barré syndrome

0 references

Cytomegalovirus

0 references

cytomegaloviral disease

1 reference

5

van der Meché FG

1 reference

13 October 2017

Jacobs BC

1

1 reference

13 October 2017

van Doorn PA

series ordinal

2

1 reference

13 October 2017

Groeneveld JH

series ordinal

3

1 reference

13 October 2017

Tio-Gillen AP

series ordinal

4

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

13 October 2017

1 reference

13 October 2017

62

1 reference

13 October 2017

6

1 reference

13 October 2017

641-643

1 reference

Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1074154

Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1074154

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1074154

Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1074154

Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1074154

A prospective study of acute idiopathic neuropathy. II. Antecedent events

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1074154

Antibody detection in Guillain-Barré syndrome

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1074154

Sural nerve biopsies in Guillain-Barre syndrome: axonal degeneration and macrophage-associated demyelination and absence of cytomegalovirus genome

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1074154

Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides

6 June 2018

1 reference

12 December 2020

Anti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection

1 reference

12 December 2020

Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome

1 reference

12 December 2020

Anti-GM1 IgA antibodies in Guillain-Barré syndrome

1 reference

12 December 2020

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

1 reference

12 December 2020

Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.62.6.641

1 reference

13 October 2017

1 reference

13 October 2017

1 reference